Ja. Madden et al., L-ARGININE-RELATED RESPONSES TO PRESSURE AND VASOACTIVE AGENTS IN MONOCROTALINE-TREATED RAT PULMONARY-ARTERIES, Journal of applied physiology, 79(2), 1995, pp. 589-593
To determine whether altered NO production contributes to attenuated d
istensibility (alpha), vasoreactivity, and acetylcholine (ACh) dilatio
n in pulmonary arteries from monocrotaline (MCT)-treated rats (J. A. M
adden, P. A. Keller, R. M. Effrosa, C. Sequitte, J. S. Choy, and A. D.
Hacker. J. Appl. Physiol. 76: 1589-1593, 1994), intralobar and sidebr
anch arteries from rats 21 days after MCT treatment were cannulated an
d pressurized and their diameter changes in response to KCl, norepinep
hrine, angiotensin II, and pressure were measured in the presence of N
-omega-nitro-L-arginine (NLA) and L-arginine. NLA treatment decreased
MCT artery diameters more than normal arteries (P < 0.05) and abolishe
d ACh dilation in both. Agonist responses were greater in normal but n
ot MCT arteries. The alpha increased in NLA-treated normal (P < 0.05)
but not MCT arteries. After L-arginine, normal and MCT arteries return
ed to control diameters and dilated to ACh. Agonist responses returned
to control in normal but not MCT arteries. Normal but not MCT arterie
s dilated in calcium-free solution (P < 0.05). These results suggest t
hat pulmonary arteries from rats with MCT-induced pulmonary hypertensi
on produce more NO than do pulmonary arteries; inhibiting NO does not
increase contractility; and decreased vasoreactivity and alpha values
are not due to smooth muscle cell tone but may be due to abnormal vasc
ular remodeling.